HMHidehito Mukai

Hidehito Mukai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hidehito Mukai has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Yoshiaki Kiso

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    6 shared publications
  • Eisuke Munekata

    5 shared publications
  • Takayuki Marutani

    Laboratory of Peptide Science, Graduate School of Bio-Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan

    3 shared publications
  • Tatsuya Hattori

    Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA

    3 shared publications
  • Tetsuo Seki

    3 shared publications
  • Yoshinori Hokari

    Laboratory of Peptide Science, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan.

    3 shared publications

Latest Publications

  • Open Access

    Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages

    by Takayuki Marutani, Kodai Nishino, Tomoyuki Miyaji, Keisuke Kamada, Koji Ohura, Yoshiaki Kiso, Hidehito Mukai

    Mitocryptides are a novel family of endogenous neutrophil-activating peptides originating from various mitochondrial proteins. Mitocryptide-2 (MCT-2) is one of such neutrophil-activating peptides, and is produced as an N-formylated pentadecapeptide from mitochondrial cytochrome b. Although MCT-2 is a specific endogenous ligand for formyl peptide receptor 2 (FPR2), the chemical structure within MCT-2 that is responsible for FPR2 activation is still obscure. Here, we demonstrate that the N-terminal heptapeptide structure of MCT-2 with an N-formyl group is the minimum structure that specifically activates FPR2. Moreover, the receptor molecule for MCT-2 is suggested to be shifted from FPR2 to its homolog formyl peptide receptor 1 (FPR1) by the physiological cleavages of its C-terminus. Indeed, N-terminal derivatives of MCT-2 with seven amino acid residues or longer caused an increase of intracellular free Ca2+ concentration in HEK-293 cells expressing FPR2, but not in those expressing FPR1. Those MCT-2 derivatives also induced β-hexosaminidase secretion in neutrophilic/granulocytic differentiated HL-60 cells via FPR2 activation. In contrast, MCT-2(1–4), an N-terminal tetrapeptide of MCT-2, specifically activated FPR1 to promote those functions. Moreover, MCT-2 was degraded in serum to produce MCT-2(1–4) over time. These findings suggest that MCT-2 is a novel critical factor that not only initiates innate immunity via the specific activation of FPR2, but also promotes delayed responses by the activation of FPR1, which may include resolution and tissue regeneration. The present results also strongly support the necessity of considering the exact chemical structures of activating factors for the investigation of innate immune responses.


  • Generation of monoclonal antibodies against mitocryptide‐2: toward a new strategy to investigate the biological roles of cryptides

    by Tatsuya Hattori, Takenori Yamada, Hiroki Morikawa, Takayuki Marutani, Koki Tsutsumi, Kodai Nishino, Toshihiro Shimizu, Yoshisuke Nishi, Yoshiaki Kiso, Hidehito Mukai

    We recently identified a novel family of neutrophil‐activating peptides including mitocryptide‐1 and mitocryptide‐2 (MCT‐2) that are endogenously produced from various mitochondrial proteins. Among them, MCT‐2 is an N‐formylated pentadecapeptide derived from mitochondrial cytochrome b and is found to promote neutrophilic migration and phagocytosis efficiently. Signaling mechanisms of neutrophil activation by MCT‐2 have been investigated at the cellular level, and MCT‐2 has been demonstrated to be an endogenous specific ligand for formyl peptide receptor‐2 (also referred to as formyl peptide receptor‐like 1). It was also found that MCT‐2 promoted neutrophilic functions via the activation of Gi2 proteins and phosphorylation of ERK1/2 consecutively. However, the physiological production, distribution, and functions of MCT‐2 are not yet elucidated. Here, to investigate the roles of MCT‐2 in vivo, we generated monoclonal antibodies (mAbs) against human MCT‐2 (hMCT‐2) that have two different characteristics. One mAb, NhM2A1, not only bound to the region of positions 10–15 of hMCT‐2 but also recognized its C‐terminal cleavage site that is presumably produced upon enzymatic hydrolysis of cytochrome b, indicating that NhM2A1 specifically interacts with hMCT‐2 but not its parent protein. Moreover, we succeeded in acquiring a specific neutralizing mAb, NhM2A5, which blocks the bioactivities of hMCT‐2. Specifically, NhM2A5 inhibited hMCT‐2‐induced β‐hexosaminidase release in neutrophilic/granulocytic differentiated HL‐60 cells by binding to the region of positions 5–12 of hMCT‐2. Functional analysis using obtained mAbs that specifically recognize hMCT‐2 but not its parent protein, cytochrome b, and that neutralize bioactivities of hMCT‐2 is expected to reveal the physiological roles of MCT‐2, which are presently very difficult to investigate. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.


  • Mitochondrial protein-derived cryptides: Are endogenousN-formylated peptides including mitocryptide-2 components of mitochondrial damage-associated molecular patterns?

    by Takayuki Marutani, Tatsuya Hattori, Koki Tsutsumi, Yusuke Koike, Akihiko Harada, Kosuke Noguchi, Yoshiaki Kiso, Hidehito Mukai

    Recently, much attention has been paid to “non-classical” bioactive peptides, which are fragmented peptides simultaneously produced during maturation and degradation of various functional proteins. We identified many fragmented peptides derived from various mitochondrial proteins including mitocryptide-1 and mitocryptide-2 that efficiently activate neutrophils. These endogenous, functionally active, fragmented peptides are referred to as “cryptides”. Among them, mitocryptide-2 is an N-formylated cryptide cleaved from mitochondrial cytochrome b that is encoded in mitochondrial DNA. It is known that thirteen proteins encoded in mitochondrial DNA are translated in mitochondria as N-formylated forms, suggesting the existence of endogenous N-formylated peptides other than mitocryptide-2. Here we investigated the effects of N-formylated peptides presumably cleaved from mitochondrial DNA-encoded proteins other than cytochrome b on the functions of neutrophilic cells in order to elucidate possible regulation by endogenous N-formylated cryptides. Four N-formylated cryptides derived from cytochrome c oxidase subunit I and NADH dehydrogenase subunits 4, 5, and 6 among twelve peptides from mitochondrial DNA-encoded proteins, efficiently induced not only migration but also β-hexosaminidase release, which is an indicator of neutrophilic phagocytosis, in HL-60 cells differentiated into neutrophilic cells. These activities were comparable to or higher than those induced by mitocryptide-2. Although endogenous N-formylated peptides that are contained in mitochondrial damage-associated molecular patterns (DAMPs) have yet to be molecularly identified, they have been implicated in innate immunity. Thus, N-formylated cryptides including mitocryptide-2 are first-line candidates for the contents of mitochondrial DAMPs to promote innate immune responses.


  • Successful acquisition of a neutralizing monoclonal antibody against a novel neutrophil-activating peptide, mitocryptide-1

    by Tatsuya Hattori, Kenta Nakashima, Takayuki Marutani, Yoshiaki Kiso, Yoshisuke Nishi, Hidehito Mukai


  • Isolation and identification of novel neutrophil-activating cryptides hidden in mitochondrial cytochrome C.

    by Yoshinori Hokari, Tetsuo Seki, Hiroko Nakano, Yuko Matsuo, Akiyoshi Fukamizu, Eisuke Munekata, Yoshiaki Kiso, Hidehito Mukai

    Abstract: Although it is known that neutrophils infiltrate damaged sites immediately after tissue injury, the endogenous factors that induce their acute transmigration and activation have not been thoroughly investigated. For the candidates of those factors, we recently discovered two novel neutrophil-activating cryptides, mitocryptide-1 (MCT-1) and mitocryptide-2 (MCT-2), hidden in mitochondrial proteins. In addition, many unknown neutrophil-activating peptides other than MCT-1 and MCT-2 were also observed during their purification. Here, we isolated and purified a novel neutrophil-activating peptide from porcine hearts, which we showed by structural analyses to have an identical primary structure to porcine mitochondrial cytochrome c (68-85). We named this novel functional octadecapeptide as mitocryptide-CYC (MCT-CYC). Structure-activity relationships of cytochrome c on β-hexosaminidase (β-HA) release from neutrophilic-differentiated HL- 60 cells demonstrated that peptides derived from the C-terminal part of cytochrome c induced β-HA release and that cytochrome c (70-85) was the most potent cryptide among them. Since cytochrome c is known to be involved in the apoptotic process, our results suggest that cryptides, including MCT-CYC, derived from mitochondrial cytochrome c are possible factors that induce scavenging of toxic debris produced from apoptotic cells by neutrophils.


    • 1 June 2010
      • Vol. 82  (6) , 524-32

    [Discovery of cryptides and their novel signaling pathways].

    by Hidehito Mukai, Yoshiaki Kiso, Kaori Wakamatsu

  • Open Access

    Mitocryptide-2: Purification, Identification, and Characterization of a Novel Cryptide That Activates Neutrophils

    by Hidehito Mukai, Tetsuo Seki, Hiroko Nakano, Yoshinori Hokari, Toshifumi Takao, Masanori Kawanami, Hiroyuki Tsukagoshi, Hirokazu Kimura, Yoshiaki Kiso, Yasutsugu Shimonishi, et al.

    Neutrophils are a class of leukocytes involved in innate immunity by monitoring and scavenging invading microorganisms and toxic substances. The actions of neutrophils in damaged tissues are still not well understood, particularly in the early stage of inflammation, and as-yet-unknown neutrophil-activating substances are proposed to induce their acute transmigration and activation. Here, we isolated and identified from porcine hearts a neutrophil-activating peptide. Structural analyses indicated that the primary structure of this peptide is formyl-Met-Thr-Asn-Ile-Arg-Lys-Ser-His-Pro-Leu-Met-Lys-Ile-Ile-Asn, which is identical to that of the N-terminal pentadecapeptide of porcine mitochondrial cytochrome b; we therefore named the newly isolated peptide “mitocryptide-2” (MCT-2), since we have recently purified and identified mitocryptide-1, a different class of a neutrophil-activating peptide. Synthetic MCT-2 and its human homolog hMCT-2 induced β-hexosaminidase release in and chemotaxis of HL-60 cells differentiated into neutrophilic/granulocytic cells. The induction of β-hexosaminidase release, chemotaxis, and the increase in the intracellular free Ca2+ concentration by hMCT-2 were completely suppressed by pertussis toxin, indicating the involvement of Gi- or Go-type G proteins in the signaling pathways. Moreover, MCT-2 and hMCT-2 also stimulated β-hexosaminidase secretion in human neutrophils isolated from peripheral blood in a concentration-dependent manner. Additionally, these peptides partially competed with [3H]formyl-Met-Leu-Phe binding to HL-60 cells differentiated into neutrophilic/granulocytic cells, presenting the possibility that the receptor for MCT-2 and hMCT-2 is one of the formyl peptide receptors. These results demonstrate that MCT-2 and its human homolog hMCT-2 are cryptides that activate neutrophils, thus suggesting the presence of regulatory mechanisms involving such mitocryptides in innate immunity.


  • Open Access

    Discovery of Mitocryptide-1, a Neutrophil-activating Cryptide from Healthy Porcine Heart

    by Hidehito Mukai, Yoshinori Hokari, Tetsuo Seki, Toshifumi Takao, Makoto Kubota, Yuko Matsuo, Hiroyuki Tsukagoshi, Masahiko Kato, Hirokazu Kimura, Yasutsugu Shimonishi, et al.


  • Cryptide signaling: Amphiphilic peptide-induced exocytotic mechanisms in mast cells

    by Hidehito Mukai, Miharu Kikuchi, Shigetomo Fukuhara, Yoshiaki Kiso, Eisuke Munekata


  • Elucidation of Structural Requirements of Mastoparan for Mast Cell Activation- Toward the Comprehensive Prediction of Cryptides Acting on Mast Cells

    by H. Mukai, Y. Suzuki, Y. Kiso, E. Munekata

    Mastoparan, a toxic peptide from wasp venom, induces various biological functions including histamine release from rat peritoneal mast cells. Here we report that, for the activation of mast cells by mastoparan, at least two positively charged side chains are required on the hydrophilic side of the amphiphilic structure of the peptide. The present results are expected to be utilized for the bioinformatic and comprehensive identification of endogenous mast cell-stimulating cryptides.